In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...
Scientists performed a first-ever clinical test of the therapy avapritinib in pediatric patients with high-grade glioma. They ...
A new therapy offers hope for treating pediatric brain tumors, targeting cancer cells while minimizing side effects for young ...
Researchers of a new study have discovered that DSRD patients showed signs of neuroinflammation and blood-brain barrier ...
For years, scientists studying brain aging have focused on proteins and DNA. But what if a crucial piece of the puzzlehas ...
High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to FDA-approved avapritinib. | Drug Discovery And Development ...